Assyro AI

FDA Orange Book · active-ingredient family

Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride

Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NULYTELY · NDA 019797

1

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · for solution

ProductApplicantApplicationTEApproved
NULYTELYRLD×2AZURITYNDA 019797AAApr 22, 1991

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDESOLIS PHARMSANDA 202060Mar 08, 2017
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDESTRIDES PHARMAANDA 204559AAApr 13, 2015
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDEEXTROVISANDA 090409Apr 02, 2010
LAX-LYTE WITH FLAVOR PACKSL PERRIGO COANDA 079232Feb 25, 2010
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDENOVEL LABS INCANDA 090019AAMay 27, 2009
TRILYTEAUROBINDO PHARMA USAANDA 076491AAFeb 05, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.